Public company
Allogene Therapeutics, Inc.
ALLOCIK 0001737287
Price$1.04
1 year-6.3%
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score25
Connections with evidence5
ALLO · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Parker Geoffrey M.CHIEF FINANCIAL OFFICER | ALLOAllogene Therapeutics, Inc. Open-market sale | SELL | $49K 36.3K sh |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
- ← Insider ofevidenceParker Geoffrey M.CHIEF FINANCIAL OFFICER · Oct 23, 2026
- ← Insider ofevidenceYoshiyama AnnieSVP, Finance · Apr 23, 2026
- ← Insider ofevidenceBeneski Benjamin MachinasSVP, Chief Technical Officer · Mar 4, 2026
- ← Insider ofevidence